1. Achieving the Total Approach in Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia (LUTS/BPH) Management 
Michael O’Leary 
European Urology Supplements 
Volume 2, Issue 7, Pages (November 2003)
DOI: /j.eursup

2. Fig. 1
Fast relief of urinary symptoms with tamsulosin vs. terazosin [14].
European Urology Supplements 2003 2, 25-33DOI: ( /j.eursup )

3. Fig. 2
Improvement in mean total, storage and voiding IPSS in LUTS/BPH patients treated with tamsulosin for 6 years [17].
European Urology Supplements 2003 2, 25-33DOI: ( /j.eursup )

4. Fig. 3
Tamsulosin is effective in relieving LUTS/BPH irrespective of prostate size [25].
European Urology Supplements 2003 2, 25-33DOI: ( /j.eursup )

5. Fig. 4
Percentage of patients with symptomatic orthostatic hypotension during orthostatic stress testing while being treated with placebo or an α1-AR antagonist [38,39].
European Urology Supplements 2003 2, 25-33DOI: ( /j.eursup )

6. Fig. 5
Adverse events reported by ≥5% of patients treated with tamsulosin 0.4mg once daily or terazosin 5mg once daily [14].
European Urology Supplements 2003 2, 25-33DOI: ( /j.eursup )

7. Fig. 6
Percentage of patients with or without abnormal ejaculation that continue treatment for LUTS/BPH in clinical trials [51].
European Urology Supplements 2003 2, 25-33DOI: ( /j.eursup )